© 2026 Sinochem Nanjing Corporation,
All Right Reserved
The story of procaterol hydrochloride traces back to late twentieth-century efforts to engineer more selective bronchodilators for asthma and chronic obstructive pulmonary disease (COPD). Researchers sought a compound with strong beta-2 adrenergic agonist action that sidestepped the worst of cardiac stimulation common to early treatments. As pharmaceutical labs combed through libraries of organic molecules, Japanese scientists broke ground in the late 1970s by deriving procaterol from phenylethanolamine, optimizing the core structure to resist rapid metabolism and support asthma management day and night. This wasn’t just a chemical milestone. It shifted how doctors approached symptom relief, especially for children sensitive to stimulant side effects. Procaterol became a reminder that incremental refinement in drug design can deliver lasting clinical gains.
Procaterol hydrochloride stands as a prescription-only bronchodilator mostly used around Asia. Its main strength lies in its ability to provide prolonged smooth muscle relaxation in the airways. Pharmaceutical companies produce the compound as a white crystalline powder, packaging it in tablets, syrups, and inhalers. Among physicians, procaterol wins favor for consistent bioavailability, onset of action within thirty minutes, and half-life long enough to smooth crises overnight. Tablets and syrups often go to pediatric and elderly patients, where ease of swallowing and tailored dosing shapes therapy. This medicine became a go-to not because of aggressive marketing, but from direct clinical need and patient tolerability shaping physician decisions.
Chemically, procaterol hydrochloride comes in as C16H22N2O3·HCl. In the lab, it looks like a fine white to off-white powder, with clear solubility in water and mild solubility in ethanol, unremarkable in taste but plainly distinctive under basic analytical assays. Its melting point hovers close to 183°C, evidence of a robust crystalline structure. The compound’s stability under normal storage room conditions encourages reliable shelf life, reducing worries for hospital dispensaries and clinics in rural regions facing shipping delays.
Manufacturers list procaterol hydrochloride’s active content, batch number, lot tracking, and expiration details front and center, as demanded by medical regulators. Tablets typically list strengths from 25 mcg to 50 mcg. Labels carry warnings, usage instructions, and contraindications in plain language. Inhaler devices include precision pointers on actuation. Each batch passes through tight specifications for impurity levels and must clear rigorous purity testing before making it to pharmacy shelves. Patients and doctors both benefit from this transparency, narrowing error by bringing specs out of obscure paperwork and into the consultation room.
Manufacturing procaterol hydrochloride involves a set of carefully controlled stages. Starting from phenylethanolamine, chemists attach aromatic and cyclohexyl groups, performing regioselective reactions followed by reduction and purification steps. Every step calls for careful adjustment of temperature, solvent choice, and reaction time. After isolating procaterol base, the hydrochloride salt forms through acidification, yielding a stable product ready for pharmaceutical formulation. This method calls for equipment to manage both organics and solvents, with active ventilation and closed process loops to guard worker safety and reduce environmental impact. Unlike some bulk pharmaceutical manufacturing, the yields show dependably high purity and recoverable solvent.
Procaterol doesn’t just sit in a package inertly; its aromatic moiety can undergo typical electrophilic substitutions, although the delivered product reaches end-users in a stable, finished form. In research or medicinal chemistry settings, slight tweaks in substituent position change not only potency but side effect signatures. The molecule’s backbone, steadfast against sunlight and mild hydrolysis, supports pharmacy technicians who powder tablets for custom pediatric suspensions. Lab work investigating analogs emphasizes position-specific methyl or halogen modifications, tried with hopes of shifting receptor selectivity or improving resistance to metabolic breakdown in the liver.
In the clinic, you’ll hear procaterol hydrochloride called by trade names like Meptin® and Mepol®, depending on regional market and formulation. Chemists, meanwhile, may jot down 8-hydroxy-5-[(1R)-1-hydroxy-2-(isopropylamino)butyl]quinolin-2(1H)-one hydrochloride in lab notebooks. Drug compendia list synonyms like procaterol HCl and (RS)-procaterol hydrochloride. This array of technical and brand names sometimes sows confusion in cross-border pharmacy shipments, making standardization and documentation ever more critical.
Procaterol manufacturing draws strict oversight. Plants must follow cGMP (current Good Manufacturing Practices) to avoid mistakes that can creep in around mixing tanks or packaging lines. Dust containment and proper waste disposal aren’t just regulatory boxes—they matter for the staff working hands-on shifts amidst fine powders. Respiratory protection, regular site audits, and ongoing training help keep accidents rare. Safety data sheets detail precautions for skin and eye contact, acute inhalation, and emergency fire-fighting. For the end-user, the main risks include tachycardia, palpitations, and, in sensitive patients, paradoxical bronchospasm. Doctors must screen candidates carefully, keeping open lines with pharmacists in both urban hospitals and smaller clinics.
Asthma and reversible airway diseases see the most frequent prescribing of procaterol hydrochloride. Pediatricians reach for liquid forms in cough variant asthma and nocturnal symptom patterns. As a specialist treating rural kids with limited health coverage, I’ve seen parents gain peace of mind from treatments that carry less risk of racing heartbeats and tremors. In parts of Asia, procaterol tablets double as add-on therapy for elderly COPD sufferers unfit for steroid inhalers. Emergency rooms stock metered dose inhalers so frontline staff can deliver prompt action during acute attacks. Geographic, cultural, and insurance landscapes shape how this compound actually serves actual people needing relief.
Across the research front, teams keep digging into ways to unlock longer duration, more selective receptor targeting, and better compatibility with combination therapies. Recent years have seen medicinal chemists probing procaterol’s metabolic fate in animal models, mapping how gut flora or genetic polymorphisms affect outcomes. In one large-scale study, children using procaterol syrup tracked similar relapse rates but fewer side effects compared to salbutamol. Laboratory experiments continue mapping off-target and receptor mutation profiles to see if next-generation modifications might support new populations: non-responders, steroid-sensitive patients, and those with frequent exacerbations. This area buzzes with patents granted for novel crystalline forms, slow-release matrices, and co-formulated products incorporating antihistamines or anticholinergics.
Toxicologists scrutinized procaterol’s safety margin through high-dose challenge studies in rodents and nonhuman primates. Fatal dose thresholds rest at several multiples above therapeutic levels. Prolonged exposure has flagged risks for cardiac muscle changes, but these findings rarely translate at approved human dosing. Reproductive safety assessments and genotoxicity screens have cleared most regulatory hurdles in markets where procaterol is available. Human side effects emerge mostly as exaggerated beta-adrenergic responses—shaky hands, racing heart, headaches. Good doctors gauge risks for each patient, especially those with known arrhythmias, diabetes, or hyperthyroid conditions. Reports have highlighted very rare paradoxical bronchospasm, emphasizing the importance of in-person monitoring at therapy start. Professionals need up-to-date continuing education to keep ahead of new toxicity findings and real-world trends.
Pharmaceutical firms tilt toward improved inhaler delivery and transdermal patches, competing not only on pharmacokinetics but on user experience and sustainability. My own predictions rest on slow, iterative therapeutic gains; the basic efficacy of beta-2 agonists seems capped by biology, shifting the race to safety and integration into multi-drug regimens. Public health systems want drugs with broad tolerability, low cost, and ease of storage. Patient groups increasingly demand transparency, pushing back against undisclosed formulation excipients and reminding regulators that not all asthma is the same. Expect more clinical trials in combination therapies, extended research into gene variations affecting procaterol metabolism, and infrastructure upgrades to distribute drugs in remote regions hit hard by rising air pollution. Every piece of this supply chain, from compound synthesis to clinical protocol, needs new investment and vigilance to keep delivering on procaterol’s early promise.
For people living with asthma or certain breathing problems, simple inhalation can turn into a struggle. Chest tightness, cough, and wheezing show up without warning, disrupting work and play. These moments steal focus from school, drain energy at work, and take away peace of mind at home. In these moments, the need for quick, reliable relief lands high on anyone's list.
Doctors turn to Procaterol Hydrochloride mostly for those fighting with asthma or other lung troubles that lead to blocked airways. This medicine belongs to a class called beta-2 agonists. These drugs work by relaxing the muscles around the airways, letting more air pass in and out of the lungs. With clearer airways, cough eases, and breathing becomes less labored.
Medical research backs up the vital role of medications like Procaterol Hydrochloride. A study in the journal Lung compared it to other treatments and found it did its job controlling sudden asthma attacks—working quickly and helping prevent stubborn symptoms. For many, this medication offers a lifeline when other options fail or bring side effects.
As someone who grew up in a family touched by asthma, I remember the worry whenever my brother struggled to catch his breath. Doctors prescribed several medications, including ones that shared the same class as Procaterol. The biggest relief didn’t come from complicated regimens, but from fast-acting tablets or inhalers. They gave us back family dinners, birthday parties, and soccer games. For many, knowing a trusted medicine is handy shapes the entire day.
People with reversible airway diseases—like certain forms of bronchitis or chronic obstructive pulmonary disease (COPD)—also find comfort in medications similar to Procaterol. These patients struggle with persistent coughing and breathlessness but may respond to bronchodilators that deliver relief without heavy side effects.
Safety matters as much as relief. Procaterol Hydrochloride, like other beta-2 agonists, should not become the only tool in the tool kit. Relying too much on it may signal poorly controlled asthma. Poor asthma control can raise the risk of worsening conditions and emergency room visits. The Global Initiative for Asthma recommends reviewing every prescription regularly and not skipping routine checkups. Combining preventive medications, like inhaled corticosteroids, with rescue medications stands as the best approach.
Doctors also warn about possible side effects—racing heart, shakiness, nervous feelings, or headaches. Open conversations between doctors and patients help keep track of any symptoms and adjust treatment plans before problems grow.
Procaterol Hydrochloride and similar asthma treatments cost more than many families can handle. In lower-income regions, just getting an accurate diagnosis may pose a real hurdle. The World Health Organization points out that global asthma deaths come mostly from places where treatment and diagnosis fall short. Better health education and affordable medications can save lives and cut suffering.
Having medicines like Procaterol Hydrochloride close by changes lives for those battling asthma or other breathing roadblocks. Regular reviews with a healthcare provider, education about asthma action plans, and making medicines affordable stand as steps that offer hope and health. Recognizing the daily challenges and revising health systems to do better—these things lead to stronger, breath-filled lives.
Doctors often call on procaterol hydrochloride for treating asthma, bronchitis, or other breathing troubles. This medicine works as a bronchodilator—helping relax the muscles lining the airways, so air moves more freely. This treatment changes lives for many kids and adults with wheezing or shortness of breath. Before I ever learned about this medication, a neighbor’s young son landed in the hospital after an asthma attack. Prompt care and the right inhaler brought him fast relief. Those memories stick with me whenever this topic comes up.
A doctor decides the amount and schedule for each person. No two people share an identical plan, especially for younger patients, seniors, or anyone with kidney or liver issues. In most cases, patients use the inhalation route, either as a metered-dose inhaler or a nebulizer solution. Kids usually use a lower dose, which helps prevent side effects. After each puff, holding the breath briefly gives the medicine a better shot at reaching deep into the lungs. Missing a dose happens. In that case, following the next regular scheduled time is best. Doubling up to catch up can lead to shaking, headaches, or a racing heart, all tied to how this drug works.
Instructions for procaterol must come from a licensed medical professional who knows the patient's health history. Using it more often or in higher amounts may look tempting during rough stretches, but that route raises the risk for jitteriness, trouble sleeping, or palpitations. Mixing procaterol with certain other medicines can spark unsafe reactions too. For instance, some antidepressants or blood-pressure drugs intensify side effects or keep the medicine from working well. Honest conversations at the pharmacy or doctor’s office avoid these pitfalls.
Families dealing with chronic asthma need more than bottles and instructions. Managing triggers—like smoke, dust, or pollen—goes hand in hand with medication. I remember coaching a friend through the process of cleaning an inhaler. Once, a clogged mouthpiece kept the dose from delivering. Those simple details, such as rinsing the mouth after each use or keeping track of canister counts, go a long way in preventing thrush and guaranteeing dependable care.
Missing or skipping treatments remains common, especially in busy households. Medication reminder apps or visible notes near toothbrushes create useful nudges. Proper inhaler technique can spell the difference between relief and frustration. Demonstrations at the clinic or pharmacy ensure folks use these devices efficiently. Schools and camps benefit from written asthma action plans, letting staff manage sudden symptoms confidently.
Anyone experiencing chest pain, rapid heartbeat, or new, unusual feelings should talk to their healthcare provider right away. Regular visits help spot dose adjustments and catch side effects early. Washing hands before handling medicine, storing inhalers away from high heat or cold, and checking expiration dates may sound simple, but they protect against contamination and wasted medicine.
Doctors, pharmacists, patients, and families all have a part in safe, effective care. Open conversations about challenges using procaterol lay groundwork for better outcomes. More public health resources that teach safe inhaler use for people of all ages could change the game in managing asthma and other lung conditions.
Procaterol Hydrochloride serves as a bronchodilator—helping people breathe easier, especially those with asthma or chronic obstructive pulmonary disease. Folks rely on medicine like this when tightness in the chest or cough kicks in. For some families, inhalers and tablets sit near the front door or kitchen counter, ready to help manage scary moments. One thing that helps: knowing what's normal and what signals something's not right.
Pounding heartbeat and shakiness mark the side effects that most people notice early on. Kids can complain of feeling jittery after a puff, and adults sometimes find their hands shake. Many report nervousness. Muscles might twitch. Sometimes that rapid heart feels like anxiety, but tracking your pulse can help tell the difference. Headaches surprise some users, and dry mouth crops up, especially after repeated doses.
Older people, or people already dealing with high blood pressure, need to be careful. Procaterol can nudge blood pressure higher and set the heart racing past a comfortable zone. Family doctors keep close tabs for patients in this group, often asking about irregular heartbeat or chest pain. People who exercise or work outside might notice they sweat more than usual, or that dizziness sneaks in after activity.
Some side effects warrant immediate action. Chest pain that won’t let up, or a heartbeat that rattles the chest, signals an urgent call for help. Breathing paradoxically gets worse for a small number of patients. Allergic reactions prove rare, but lips, face, or throat swelling needs emergency care. Insomnia can disrupt sleep, and in some kids, mood swings or hyperactivity pop up—parents often notice personality changes before teachers do.
Most people don’t talk with their doctors as often as they should. Pharmacists and nurse practitioners see firsthand how questions about medicines stack up. Tracking symptoms after starting procaterol can save a lot of guess-work. Simple habits—like keeping a symptoms diary, or setting reminders for follow-up visits—give everyone a clearer picture. Multiple sources, including recent guidance from the Mayo Clinic and Health Canada, suggest that side effects remain manageable when caught early.
Reading every bit of information that comes in the box helps. Call the pharmacy before any new medicine, even over-the-counter flu or allergy pills. Mixing drugs often leads to unwanted surprises, so keeping a medication list in your wallet or phone can help any doctor spot a bad mix. If something doesn’t feel right, getting checked out sooner rather than later beats waiting for a crisis. For kids, teachers and school nurses should know about prescribed inhalers so they can spot issues, too.
Doctors and staff could make a habit of checking in within days—not weeks—after starting or adjusting procaterol. Insurance plans that support follow-up calls and education make a real difference. As families and patients, speaking up about every unusual reaction builds trust and better health outcomes. Proper use, honest answers, and teamwork between patients and professionals remain the keys to staying healthy while harnessing the benefits of procaterol.
Doctors hand out prescriptions for breathing problems every day, and procaterol hydrochloride pops up often for its ability to open airways quickly. Kids with asthma and folks dealing with COPD count on it. But not every medicine fits every person, and skipping over side effects because of trust in authority can set patients up for trouble.
Procaterol targets the lungs, but gets the heart involved, too. The medicine can rev up the heart rate and sometimes set off palpitations, tremors, or spikes in blood pressure. People already living with heart issues like arrhythmia or uncontrolled hypertension face more risk when these stimulants work through their system. Ignoring these red flags out of habit strains trust in healthcare—especially for patients who have had negative experiences due to overlooked contraindications in the past.
Asthma attacks are scary, but that doesn’t erase the importance of caution. Children under six have a higher chance of side effects because of their less mature immune and cardiovascular systems. Elderly people who often juggle multiple prescriptions can run into unexpected drug interactions. Thyroid issues, especially overactive thyroid, need a closer look because procaterol can amplify symptoms. Diabetes gets trickier, too—beta-agonists may bump up blood sugar levels, and without regular checks, that can throw off even the best-managed diabetes.
Polypharmacy isn’t rare these days. Antidepressants, certain antibiotics, and even common cold medicines can tangle with procaterol in ways that go unnoticed until something goes wrong. For example, combining procaterol with MAO inhibitors or tricyclic antidepressants can raise blood pressure risks. Some medications exaggerate procaterol's effects on the heart, making the mix risky enough to land someone in an ER.
Some patients may brush off mild dizziness or skin itch, seeing them as normal. In fact, these early signs sometimes point to allergic responses that could get severe. For people with a history of sensitivity to beta-agonists or ingredients in the inhaler, switching to another asthma medication becomes necessary—not just a preference.
Many families ask about the safety of asthma inhalers during pregnancy and breastfeeding. There isn’t enough human data to claim absolute safety for unborn babies. Animal studies suggest potential risks, and this uncertainty forces a close discussion between patient and provider. Open conversations with the provider matter more at these times than any blanket statement found on a drug label.
Everyone benefits when doctors and patients slow down and go over history and current medications face to face. Regular check-ins on side effects, even ones that seem small, catch problems early. Extra education for pharmacists and caregivers on what to watch for helps too. In my experience talking to patients and healthcare workers, I’ve found that taking a few extra minutes can change the course of someone’s care, helping them get relief without surprise complications.
Procaterol hydrochloride shows up on pharmacy shelves as a reliever for wheezing and shortness of breath. Most folks who work in a clinic or a hospital have written the drug name on the prescription pad for patients with asthma or bronchitis. The medicine acts as a bronchodilator, coaxing tight airways to relax, and it usually comes as a syrup or tablet.
Parents want clear answers when their children get sick. Kids with asthma deserve fast relief, but every adult worries about side effects. Procaterol hydrochloride gets attention because it acts sharply, but there are reports of kids feeling jittery, having a racing heart, or struggling to sleep.
Clinical studies confirm that children process this medicine differently than adults. For example, a child’s smaller body and developing organs can turn a common dose into a risky one if it isn’t carefully managed. The World Health Organization and major pediatric guidelines in countries like Japan give approval for procaterol syrup use in kids, but they recommend strict dosage checks and regular follow-up. Even so, in countries such as the United States or many parts of Europe, this drug isn’t commonly prescribed to children anymore, in part because alternatives with long-term safety data exist.
Families need to talk with trained professionals before giving this bronchodilator to a child. Blood pressure, heart rhythm, and blood sugar may fluctuate with its use, which is a particular concern for kids with other health problems.
Expecting mothers often ask whether they can keep using their asthma medications. It's a good question, because asthma attacks can put mother and baby in danger. Most health authorities still urge caution with procaterol hydrochloride in pregnancy. Only a handful of animal studies and small patient trials touch the subject, and those trials haven’t cleared up all the uncertainties.
Studies show that medications like procaterol may increase the chance of a higher heart rate for both the mother and fetus. Some studies raise the possibility of low birth weight or preterm labor if the mother uses strong bronchodilators over an extended period. The full impact remains unclear, so most doctors look for treatment options with a stronger safety profile.
Doctors with experience in asthma management during pregnancy usually stick with tried-and-true options such as inhaled corticosteroids or beta-2 agonists that have been tracked for many years. They discuss the potential benefits and concerns openly with pregnant women and encourage honest conversations about symptom control versus medication risks.
Families and pregnant women facing asthma need more straightforward research and updates from trusted health sources. Transparent guidance from health professionals who follow the evidence brings peace of mind and keeps people safer. Parents and pregnant women often push for answers doctors don’t have, and that’s a fair request.
For now, most patients do better on medications with long track records and strong safety data, but every case deserves its own conversation. Health professionals keep learning, and as new research comes out, advice will keep getting better.
| Names | |
| Preferred IUPAC name | 8-hydroxy-5-[(1R)-1-hydroxy-2-(isopropylamino)ethyl]-2H-chromen-2-one hydrochloride |
| Other names |
ON-3017 Procaterol hydrochloride hemihydrate |
| Pronunciation | /ˈproʊˌkætəˌrɒl haɪˈdrɒklaɪd/ |
| Identifiers | |
| CAS Number | [ "81262-93-3" ] |
| Beilstein Reference | Beilstein Reference: 4151380 |
| ChEBI | CHEBI:135181 |
| ChEMBL | CHEMBL2106659 |
| ChemSpider | 144505 |
| DrugBank | DB09221 |
| ECHA InfoCard | 03d17336-9168-472e-aff9-3f473860fa4c |
| EC Number | 61999-45-5 |
| Gmelin Reference | 84159 |
| KEGG | D08457 |
| MeSH | D016206 |
| PubChem CID | 65666 |
| RTECS number | GF5321000 |
| UNII | N3T12K6Z7Y |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID8046657 |
| Properties | |
| Chemical formula | C16H22N2O2·HCl |
| Molar mass | 329.2 g/mol |
| Appearance | white crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm3 |
| Solubility in water | Very soluble in water |
| log P | -1.3 |
| Acidity (pKa) | 8.9 |
| Basicity (pKb) | 3.2 |
| Magnetic susceptibility (χ) | -79.5×10^-6 cm^3/mol |
| Refractive index (nD) | 1.434 |
| Dipole moment | 2.83 D |
| Pharmacology | |
| ATC code | R03AC16 |
| Hazards | |
| Main hazards | Causes respiratory tract irritation, harmful if swallowed, may cause allergic reactions. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHSA, GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: Store below 30°C. Protect from light and moisture. Keep out of reach of children. For use only under the prescription of a physician. |
| Flash point | > Flash Point: 249.5°C |
| Lethal dose or concentration | Lethal dose or concentration (LD50) of Procaterol Hydrochloride: "LD50 (mouse, oral): 303 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral LD50 = 2500 mg/kg |
| NIOSH | Not Established |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.025 mg |
| Related compounds | |
| Related compounds |
Fenoterol Salbutamol Orciprenaline Terbutaline |
